|By Business Wire||
|July 22, 2014 01:44 PM EDT||
VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has amended its Health Canada Medical Device License to include M-Vu Breast Density. The amendment provides clearance for VuCOMP to sell and market its M-Vu Breast Density product throughout Canada.
The clearance is timely as bill C-314, An Act Respecting the awareness of screening among women with dense breast tissue has been introduced in Canada. The act requires the Government of Canada to encourage the use of existing initiatives in order to increase awareness among women about the implications of heterogeneous or dense breast tissue for breast cancer screening, and to assist women and health care providers in making well-informed decisions regarding screening.
Jim Pike, President and CTO of VuCOMP stated, “We are pleased to now offer M-Vu Breast Density to the breast radiology community in Canada. Breast cancer is the second leading cause of death from cancer in Canadian women, with over 24,000 women diagnosed each year. We hope our M-Vu Breast Density tool will aid radiologists as they fight to lower this statistic.”
Clinical studies have shown that dense breasts can hide a cancerous lesion by reducing the ability to visualize fine structures and details that could indicate a malignant abnormality, making breast cancer detection in a mammogram more difficult. M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer.
In addition to M-Vu Breast Density, clinics around the world are using the company’s M-Vu® Computer-Aided Detection (CAD) for mammography. M-Vu CAD analyzes mammograms to mark areas consistent with breast cancer using sophisticated mathematical algorithms.
About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for CAD and automated breast density measurement. The company is dedicated exclusively to developing advanced cancer detecting technologies. VuCOMP’s engineering team has worked together since 1986, pioneering some of the world’s most advanced computer vision systems. For more information, please visit www.vucomp.com.
Mar. 30, 2017 05:30 PM EDT Reads: 1,239
Mar. 30, 2017 05:30 PM EDT Reads: 4,036
Mar. 30, 2017 04:30 PM EDT Reads: 3,521
Mar. 30, 2017 04:15 PM EDT Reads: 4,387
Mar. 30, 2017 04:15 PM EDT Reads: 3,417
Mar. 30, 2017 03:45 PM EDT Reads: 6,764
Mar. 30, 2017 03:30 PM EDT Reads: 2,425
Mar. 30, 2017 03:17 PM EDT Reads: 292
Mar. 30, 2017 03:15 PM EDT Reads: 1,101
Mar. 30, 2017 02:45 PM EDT Reads: 1,051
Mar. 30, 2017 02:45 PM EDT Reads: 4,030
Mar. 30, 2017 02:45 PM EDT Reads: 2,505
Mar. 30, 2017 02:00 PM EDT Reads: 9,041
Mar. 30, 2017 01:58 PM EDT Reads: 259
FinTech is the sum of financial and technology, and it’s one of the fastest growing tech industries. Total global investments in FinTech almost reached $50 billion last year, but there is still a great deal of confusion over what it is and what it means – especially as it applies to retirement. Building financial startups is not simple, but with the right team, technology and an innovative approach it can be an extremely interesting domain to disrupt. FinTech heralds a financial revolution that...
Mar. 30, 2017 01:45 PM EDT Reads: 3,230